Source link : https://www.newshealth.biz/health-news/kras-inhibitors-in-pancreatic-cancer-hope-on-the-horizon/
Pancreatic cancer remains one of the deadliest cancers. When the disease is caught earlier, the 5-year survival rates hover around 44%, but once the cancer metastasizes, only about 3% of patients live that long. Finding effective treatments for the disease continues to be a challenge. No significant new therapies in pancreatic cancer have emerged in […]
Author : News Health
Publish date : 2024-09-06 15:43:53
Copyright for syndicated content belongs to the linked Source.